Table: begin end state 1 6 cytoplasmic 7 35 transmembrane 36 54 non-cytoplasmic 55 75 transmembrane 76 82 cytoplasmic 83 108 transmembrane 109 112 non-cytoplasmic 113 131 transmembrane 132 137 cytoplasmic 138 162 transmembrane 163 170 non-cytoplasmic 171 193 transmembrane 194 212 cytoplasmic 213 235 transmembrane 236 240 non-cytoplasmic 241 258 transmembrane 259 277 cytoplasmic 278 297 transmembrane 298 306 non-cytoplasmic 307 327 transmembrane 328 338 cytoplasmic 339 362 transmembrane 363 368 non-cytoplasmic 369 398 transmembrane 399 404 cytoplasmic 405 428 transmembrane 429 429 non-cytoplasmic 430 453 transmembrane 454 467 cytoplasmic
Input: >GFF2033 MDVVLLFSMVIGLLLIGVPIAVALGLSSTLFLLIYSDSSLASVAGTLFEAFEGHFTLLAI PFFILASSFMTTGGVARRIIRFSIACVGHLPGGLAIAGVFACMLFAALSGSSPATVVAIG SIVIAGMRQVGYSKEFAAGVICNAGTLGILIPPSIVMVVYAAAVEVSVGRMFLAGVIPGL MAGLMLMVTIYVMAKVKNLPKGEWLGWGEVAASAANASVGLLLIGIILGGIYGGIFTPTE AAAVASVYAFFVATFVYRDMGPLKSAPKPKDMGQFLTMLPKMLGQTVVYFIPSFFHADTR HALFEAGKLTVTLLFVIANALILKHVLTDEQVPQQIATAMLSAGFGPVMFLIVVNVILLI GGQFMEPSGLLVIVAPLVFPIAIELGIDPIHLGIIMVVNMEIGMITPPVGLNLFVTSGVA GMPMMAVVRAALPFLAVLFVFLIMITYIPWISTVLPNAVMGPEIITK
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server